People

Stephanie Singer

Attorney

Singer, Stephanie

Stephanie Singer provides practical legal and business advice to entrepreneurs, startups and high-growth companies throughout their lifecycle. She represents a wide range of technology and life sciences companies on formation, equity-related matters, corporate governance, venture capital financings, mergers and acquisitions, and ongoing corporate matters. In addition, she represents venture capital funds in making portfolio investments. Ms. Singer also has considerable experience with public offerings, public company counseling and fund formation. Prior to joining WilmerHale, Ms. Singer worked at Highland Capital Partners and at Entrepreneur magazine.

Recent Highlights

  • Represented Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies to unlock gene control and treat serious genetic diseases, in its Series A financing
  • Represented Aquinnah Pharmaceuticals, a biotechnology company focused on RNA binding proteins for neurodegenerative diseases, in a $15 million investment
  • Represented Reflexis, a leader in retail real-time execution and workforce management solutions, in a minority equity investment
  • Represented SyncOnSet Technologies, a leading entertainment technology company digitizing physical production and managing creative content, in its $1.5 million Series A financing
  • Represented Aushon BioSystems, a global provider of protein biomarker measurement and analysis products and services, in its $6.14 million Series C financing
  • Represented Syros Pharmaceuticals, a life sciences company, in its IPO
  • Represented Accion Systems, a space technology startup led by MIT graduates, in its $7.5 million Series A funding
  • Represented Acacia Communications, a leading provider of high-speed coherent optical interconnect products, in its IPO

Publications & News

View

October 5, 2017

WilmerHale Reps Disarm Therapeutics in $30M Series A Financing

Disarm Therapeutics, a new biotechnology company developing therapeutics to treat patients with neurological diseases by preventing axonal degeneration, announced the recent completion of a $30 million Series A financing.

October 3, 2017

WilmerHale Counsels Suono Bio in Seed Funding Led by Polaris and MIT’s The Engine

Suono Bio, a company developing a platform technology designed to enable ultra-rapid delivery of therapeutics—including proteins and nucleic acids—to the gastrointestinal tract, has announced that it has raised its seed funding round from Polaris, MIT's “The Engine” and other investors.

May 18, 2017

Changing Lives One Small Step at a Time

Lawyers Clearinghouse details Jonathan Wolfman and Stephanie Singer's work for One Can Help, a nonprofit that provides resources for Massachusetts' neediest children and parents involved in the juvenile court system. Wolfman and Singer helped create the infrastructure needed to handle more One Can Help employees and answered questions about board structuring, governance and tax implications.

May 10, 2017

WilmerHale Represents Fulcrum Therapeutics in Series A Financing from GV

Fulcrum Therapeutics announced that it has secured additional Series A funding from GV (formerly Google Ventures) to support the continued advancement of its lead programs in Fragile X syndrome and Fascioscapularhumeral muscular dystrophy.

April 25, 2017

WilmerHale Counsels Aquinnah Pharmaceuticals in $10M Investment From Pfizer and AbbVie

Aquinnah Pharmaceuticals announced that Pfizer Inc. and AbbVie Inc. have invested in their work to treat Amyotrophic Lateral Sclerosis, Alzheimer's disease and other neurodegenerative diseases.

April 5, 2017

WilmerHale Counsels Reflexis to Accelerate Growth With Investment From Great Hill Partners

Reflexis, the leader in retail real-time execution and workforce management solutions, announced that it has received a minority equity investment from Great Hill Partners.

January 12, 2017

SyncOnSet Technologies Secures $1.5M Series A Financing

SyncOnSet was born out of a simple idea: replace the three-ring production binder with professional software designed for how production teams work.

July 22, 2016

Third Rock Ventures Launches Fulcrum Therapeutics with $55M Series A Investment

Third Rock Ventures, LLC announced the launch of Fulcrum Therapeutics, a company focused on unlocking gene control mechanisms to develop small molecule therapies.

July 20, 2016

WilmerHale Advises Aushon BioSystems in $6.14M Series C Financing

Aushon BioSystems, a global provider of protein biomarker measurement and analysis products and services via an innovative, cost-effective multiplex immunoassay platform, announced that it held the initial closing of a $6.14 million Series C Financing.

July 5, 2016

WilmerHale Advises Syros Pharma in Initial Public Offering

WilmerHale advised Syros Pharmaceuticals, Inc., a life sciences company, in its initial public offering.

Speaking Engagements

Pro Bono

Ms. Singer's pro bono practices focuses primarily on nonprofit organizations. Ms. Singer has assisted multiple charitable organizations in obtaining 501(c)(3) status from the IRS, and she assists nonprofits with ongoing compliance and corporate governance matters. Ms. Singer also assists organizations who have lost their 501(c)(3) status or are otherwise out of compliance regain compliance with federal and state authorities.

Community Involvement

Ms. Singer regularly presents to students at local universities on startup topics. She is heavily involved with the Jonathan Nelson Center for Entrepreneurship at Brown University, and has also given presentations at Boston University, Suffolk Law School and Harvard Law School. Ms. Singer counsels students through Harvard's Innovation Lab.

Ms. Singer is also involved in Combined Jewish Philanthropies, through the Women's Division and the Lawyers' and Accountants' Division, as well as other community organizations including 100 Women of Needham and her children's schools.

Practices

Skip Navigation Links.

Education

JD, cum laude, Harvard Law School, 2010, Editor-in-Chief, The Harvard Negotiation Law Review

AB, Cognitive Science and Judaic Studies, magna cum laude, Brown University, 2004, Phi Beta Kappa

Bar Admissions

Massachusetts

Skip Navigation Links.